Effects of lipoxin A4 on hepatocyte growth factor-induced angiogenesis-related cytokines in HepG2 cells
ZHOU Xiao-yan,WANG Hong-mei,CAI Zhen-yu,XU Fang-yun,HUANG Yong-hong,ZHU Jun,WU Ping,YE Du-yun
DOI: https://doi.org/10.3969/j.issn.1000-4718.2011.02-017
2011-01-01
Abstract:AIM: To explore the possibility that lipoxin A4(LXA4) regulates the expression of angiogenesis-related cytokines in HepG2 cells induced by hepatocyte growth factor(HGF).METHODS: The HepG2 cells were divided into control group,HGF treatment group,HGF+LXA4 treatment group and HGF+BML-111(an agonist of lipoxin A4 receptor) treatment group.The expression of lipoxin A4 receptor in HepG2 cells was measured by RT-PCR.The protein levels of COX-2,MMP-2,MMP-9,IκBα and NF-κB p65 in the cells were determined by Western blotting.The release of TNF-α,IL-1β,VEGF and TGF-β in the supernatants of the cell culture was examined by ELISA.The activity of NF-κB transcription in HepG2 cells was tested by transfection and luciferase activity assay.RESULTS: The expression of lipoxin A4 receptor was detected in HepG2 cells.LXA4 and BML-111 were able to down-regulate HGF-induced production of COX-2,MMP-2 and MMP-9.The secretion of TNF-α,IL-1β,VEGF and TGF-β was also decreased.Furthermore,LXA4 and BML-111 restrained HGF-induced IκBα degradation,NF-κB translocation,and the transcriptional activity of NF-κB in HepG2 cells.CONCLUSION: LXA4 is able to inhibit HGF-induced angiogenesis-related cytokines,including VEGF,COX-2,TNF-α,IL-1β,TGF-β,MMP-2 and MMP-9,by inhibition of NF-κB activation.